The Global Fund to Fight AIDS, Tuberculosis, and Malaria revealed that, with its support, three organizations engaged in the fight against AIDS in South Africa have initiated an order for 16,000 of these innovative rings. These rings are expected to become available to the public in the coming months.
Global Fund executive director Peter Sands expressed optimism about the potential of this new approach to HIV prevention, stating, "We are convinced that this new (pre-exposure prophylaxis) ring can have a revolutionary impact on HIV prevention."
The silicone ring is designed to be worn continually and replaced on a monthly basis, releasing an antiretroviral drug called dapivirine.
This initial rollout marks the first step in expanding access to treatment and making these rings widely accessible in a country where nearly 8 million people are living with HIV, as reported by the Global Fund.
While antiretroviral drugs have been instrumental in containing the virus and preventing its transmission over the past few decades, methods like daily pills or monthly injections for pre-exposure prophylaxis may not be suitable for everyone, according to AIDS charities.
The Global Fund, an alliance of governments, multilateral agencies, private organizations, and civil society groups, notes that some individuals may struggle to remember to take daily pills or may prefer a more discreet method, especially considering the stigma associated with HIV.
Ntombenhle Mkhize, CEO of the AIDS Foundation of South Africa, said the importance of providing women with a variety of safe and effective options, including the dapivirine ring, to empower them to choose the approach that best suits their needs.
South Africa has a complex history with HIV, marked by challenges in providing affordable access to life-saving drugs in the late 1990s, leading to a significant loss of life. While fatalities have since decreased, new infections remain high.
Recent studies have demonstrated that the dapivirine ring, endorsed by the World Health Organization, is safe, easy to use, and substantially reduces the risk of infection. In 2023, women and girls accounted for 53 percent of all HIV infections worldwide, according to UNAIDS.
